A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection
Clinical trial NCT05729568 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05729568
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2024-07-02
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.